Handling of embryos from in vitro fertilisation
With in vitro fertilisation (IVF), embryos are produced outside the body. The charts below show how many embryos are produced in Switzerland and what types of genetic testing are performed.
If a couple decides to pursue in vitro fertilisation (IVF), the treatment cycle begins with hormone stimulation in the woman. This is designed to promote the maturation of oocytes. The mature oocytes are then retrieved and combined with sperm cells. In Switzerland, a maximum of twelve embryos may be produced in this way within a treatment cycle.
After embryos have been produced in vitro, the procedure may be continued in various ways. By means of PGD (preimplantation genetic diagnosis) the embryos can be tested for a specific genetic defect (preimplantation genetic testing for monogenetic disorders or PGT-M) or for a specific structural chromosomal disorder (preimplantation genetic testing for structural rearrangements or PGT-SR). Finally, embryos can also be tested for spontaneously occurring numerical chromosomal disorders (preimplantation genetic testing for aneuploidy or PGT-A). If there is no need to test the embryos they can also be transferred directly to the woman’s uterus. The attempt to establish a pregnancy may also be deferred. In this case, the embryos are cryopreserved. Ideally, to avoid multiple pregnancies, only one embryo will be transferred. The other embryos may be cryopreserved. The couple may, however, also decide to have their embryos destroyed. Such a decision may be due to failure of embryo development, the presence of a genetic or chromosomal disorder, or a desire not to proceed with assisted reproduction. Surplus embryos can also be made available for research.
The following charts show how many embryos undergo each of the various processes.
Number of embryos: development and use
Number of embryos created and obtained
Number of embryos undergoing preimplantation diagnosis
Embryo transfer, by number of embryos transferred
Number of embryos destroyed: reason for destruction
In 2017, under the revised Reproductive Medicine Act, it became possible to test embryos for a genetic disorder in Switzerland. Accordingly, up to 2016, no data is available concerning the reason “genetic disorder”.
Essentially, it is always up to the couple to decide what happens to an embryo. The couple also have the option of discarding an embryo in the absence of medical reasons. In the chart, this is recorded as “Couple’s decision”.
If one of the parents dies, no further use may be made of an embryo. The couple or one parent may also revoke consent for embryo preservation. In addition, preservation is limited to a maximum period of ten years. In the chart, these reasons for the destruction of embryos are recorded as “Other reasons”.
Further information
Index
Further topics
Assisted reproductive techniques
How many couples make use of insemination? At what age do women decide to pursue in vitro fertilisation (IVF)? What types of genetic test are conducted on embryos? Data can be found here.
Pregnancy and birth after in vitro fertilisation
How successful are IVF treatments? The charts on this page show the success rates for IVF and the numbers of premature or multiple births occurring after IVF.
Preservation of reproductive cells (precautionary measure and donation)
Anyone may have their reproductive cells or their ovarian or testicular tissue preserved. Data on preservation can be found here.
Reproductive Medicine Act effectiveness review
The Federal Office of Public Health has been commissioned to review the effectiveness of the Reproductive Medicine Act (RMA). The aim of the review is to investigate whether the Act is being implemented effectively and appropriately and whether it is achieving its objectives.

Reproductive medicine
Some 3,200 couples embark on an assisted reproductive treatment every year in Switzerland. Assisted reproductive techniques are evolving rapidly and raise complex ethical and legal questions.
Federal Office of Public Health FOPH
Biosafety, Human Genetics and Reproductive Medicine Section
Schwarzenburgstrasse 157
Switzerland - 3003 Bern